In what has been the busiest week for European biotechnology stocks for several years, investors flooded back into the sector in a series of transactions in Sweden, Germany and Belgium. Several more are in the offing, some of which are already fully guaranteed. (BioWorld International) Read More
No Abstract BioWorld International CorrespondentCellerix raised €27 million (US$40.6 million) in the first closing of a new investment round, which it aims to expand to €35 million by year-end. Read More
